Success for Non-Animal Testing of Preclinical Toxicity?
Can non-animal testing methods be used in preclinical drug discovery? Here is what the evidence is for their accuracy and limits assessing preclinical toxicity.
Type at least 2 characters to search
Success for Non-Animal Testing of Preclinical Toxicity?
Can non-animal testing methods be used in preclinical drug discovery? Here is what the evidence is for their accuracy and limits assessing preclinical toxicity.
Strategic Pharma Intelligence Drives Better Decisions in Life Sciences
Find out why strategic pharma intelligence is needed to connect insights and to guide confident decision-making across the drug development lifecycle.
Why the U.S. Medicine Supply Chain Is One Shortage Away from Crisis
The USP's 2025 Vulnerable Medicines List flags 100 drugs at high risk. Here is what to do to build pharma supply chain resilience.
Seven Ways AI Is Solving Pharmaceutical Supply Chain Problems
AI is tackling the pharmaceutical supply chain's most persistent problems, from demand forecasting to counterfeit detection. See the top 7 ways AI is improving supply chain resiliency.
The Looming Threat of Geopolitical Risk in Clinical Supply Chains
Geopolitical risk is reshaping how clinical supply chains are managed, demanding resilience and foresight. Learn why building supply chain resilience is the key for clinical trial success.
Healthcare Supply Chains in Africa: Lessons from COVID-19
COVID-19 exposed major weaknesses in pharmaceutical supply chains. In this episode of Chain Reaction, Trisha Pillay and Émile Malan explore how AI, regulatory reform, and local manufacturing could strengthen healthcare resilience.
No result found for